[HTML][HTML] Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis

Z Li, S Liu, F Li, Y Li, Y Li, P Peng, S Li, L He… - Frontiers in …, 2022 - frontiersin.org
Background Older adults are more susceptible to severe health outcomes for coronavirus
disease 2019 (COVID-19). Universal vaccination has become a trend, but there are still …

[HTML][HTML] A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults

K Xu, Z Wang, M Qin, Y Gao, N Luo, W Xie… - Frontiers in …, 2023 - frontiersin.org
In the coronavirus disease 2019 (COVID-19) pandemic, vaccinations were essential in
preventing COVID-19 infections and related mortality in older adults. The objectives of this …

Underrepresentation of older adults in clinical trials on COVID-19 vaccines: a systematic review

N Veronese, M Petrovic, A Benetos, M Denkinger… - Ageing Research …, 2021 - Elsevier
During the COVID-19 pandemic older subjects have been disproportionately affected by the
disease. Vaccination is a fundamental intervention to prevent the negative consequences of …

[HTML][HTML] Efficacy and safety of COVID-19 vaccination in older adults: a systematic review and meta-analysis

L Zhang, L Jiang, T Tian, W Li, Y Pan, Y Wang - Vaccines, 2022 - mdpi.com
Objective: To analyze the differences in efficacy and safety of different types of novel
coronavirus pneumonia (COVID-19) vaccines in different age groups (young adults and …

[HTML][HTML] The impact of age difference on the efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis

J Wang, Y Tong, D Li, J Li, Y Li - Frontiers in immunology, 2021 - frontiersin.org
Objective This meta-analysis compared the efficacy and safety of five kinds of COVID-19
vaccines in different age groups (young adults and older adults), aiming to analyze the …

[HTML][HTML] Review of COVID-19 vaccines and their evidence in older adults

SP Teo - Annals of geriatric medicine and research, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant …

Efficacy and safety of COVID-19 vaccines in older people

RL Soiza, C Scicluna, EC Thomson - Age and ageing, 2021 - academic.oup.com
Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of
regulatory approval. Their safety and efficacy in older people is critical to their success. Even …

Importance of COVID-19 vaccine efficacy in older age groups

M Sadarangani, BA Raya, JM Conway, SA Iyaniwura… - Vaccine, 2021 - Elsevier
Importance An effective vaccine against SARS-CoV-2 will reduce morbidity and mortality
and allow substantial relaxation of physical distancing policies. However, the ability of a …

It is time to improve the acceptance of COVID‐19 vaccines among people with chronic diseases: A systematic review and meta‐analysis

Y Zhao, J Du, Z Li, Z Xu, Y Wu, W Duan… - Journal of Medical …, 2023 - Wiley Online Library
This study aims to investigated COVID‐19 vaccine acceptance among people with chronic
diseases and the factors correlating with their vaccination hesitancy. The articles were …

[HTML][HTML] Effectiveness of inactivated COVID-19 vaccines among older adults in Shanghai: retrospective cohort study

Z Huang, S Xu, J Liu, L Wu, J Qiu, N Wang… - Nature …, 2023 - nature.com
We conducted a matched retrospective cohort study of two cohorts to estimate inactivated
vaccine effectiveness (VE) and its comparative effectiveness of booster dose among older …